Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study

PloS One
Anouk N A van der Horst-SchriversThera P Links

Abstract

Patients with differentiated thyroid cancer (DTC) are treated with (near)-total thyroidectomy followed by remnant ablation. Optimal radioiodine-131 (131I) uptake is achieved by withholding thyroid hormone (THW), pretreatment with recombinant human Thyrotropin Stimulating Hormone (rhTSH) is an alternative. Six randomized trials have been published comparing THW and rhTSH, however comparison is difficult because an uniform definition of ablation success is lacking. Using a strict definition, we performed an observational study aiming to determine the efficacy of rhTSH as preparation for remnant ablation. Adult DTC patients with, tumor stage T1b to T3, Nx, N0 and N1, M0 were included in a prospective multicenter observational study with a fully sequential design, using a stopping rule. All patients received remnant ablation with 131I using rhTSH. Ablation success was defined as no visible uptake in the original thyroid bed on a rhTSH stimulated 150 MBq 131I whole body scan (WBS) 9 months after remnant ablation, or no visible uptake in the original thyroid bed on a post therapeutic WBS when a second high dose was necessary. After interim analysis of the first 8 patients, the failure rate was estimated to be 69% (90% confidence inte...Continue Reading

References

Nov 1, 1994·The American Journal of Medicine·E L Mazzaferri, S M Jhiang
Jan 14, 2000·The Journal of Clinical Endocrinology and Metabolism·A F CailleuxM Schlumberger
Mar 16, 2000·Thyroid : Official Journal of the American Thyroid Association·C WestburyC Harmer
Apr 22, 2005·British Journal of Clinical Pharmacology·J K Aronson
May 27, 2006·European Journal of Endocrinology·Furio PaciniUNKNOWN European Thyroid Cancer Taskforce
Oct 13, 2006·The Journal of Clinical Endocrinology and Metabolism·Allan HackshawJayne A Franklyn
Jan 4, 2007·Thyroid : Official Journal of the American Thyroid Association·Jacqueline JonklaasSteven I Sherman
Apr 12, 2007·The Journal of Clinical Endocrinology and Metabolism·M SchlumbergerE Benhamou
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ate G J Van der ZeeWim J Sluiter
Jun 24, 2008·European Journal of Endocrinology·Robbert B T VerkooijenMarcel P M Stokkel
Aug 2, 2008·European Journal of Nuclear Medicine and Molecular Imaging·M LusterUNKNOWN European Association of Nuclear Medicine (EANM)
Oct 29, 2009·Thyroid : Official Journal of the American Thyroid Association·UNKNOWN American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid CancerR Michael Tuttle
Sep 8, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Paolo Zanotti-Fregonara, Elif Hindié
Nov 11, 2010·Thyroid : Official Journal of the American Thyroid Association·Wendy SacksGlenn D Braunstein
Feb 10, 2012·Clinical Oncology : a Journal of the Royal College of Radiologists·U MallickUNKNOWN IoN Trial Management Group
Feb 22, 2012·The Journal of Clinical Endocrinology and Metabolism·Claire SchvartzMichel Toubeau
May 4, 2012·The New England Journal of Medicine·Martin SchlumbergerUNKNOWN Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial
May 4, 2012·The New England Journal of Medicine·Ujjal MallickAllan Hackshaw
Jul 4, 2012·Nature Reviews. Endocrinology·Thera P Links, Anouk N A van der Horst-Schrivers
Mar 30, 2013·The Journal of Clinical Endocrinology and Metabolism·Megan R HaymartJennifer J Griggs
Jan 13, 2015·Journal of the Royal Society of Medicine·Austin Bradford Hill

❮ Previous
Next ❯

Citations

Dec 11, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Seong Young KwonUNKNOWN Korean Society of Nuclear Medicine (KSNM) Thyroid Cancer Clinical Trial Network (CTN) Retrospective Cohort Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.